Report - 1 Tazarotene Capsules in the Treatment of Psoriasis FDA Advisory Committee Meeting July 12, 2004 Patricia S. Walker MD, PhD Vice President, Skin Care Pharmaceuticals.

Please pass captcha verification before submit form